Greenwich Lifesciences Inc
NASDAQ:GLSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Greenwich Lifesciences Inc
NASDAQ:GLSI
|
US |
|
BASF India Ltd
BSE:500042
|
IN |
|
Sysmex Corp
F:0YX0
|
JP |
|
Nanobiotix SA
F:5NRA
|
FR |
|
P
|
Prolexus Bhd
KLSE:TECHBASE
|
MY |
|
Pidilite Industries Ltd
BSE:500331
|
IN |
|
D
|
Dolby Laboratories Inc
XBER:FUO
|
US |
|
T
|
Thunder Bridge Capital Partners IV Inc
NASDAQ:THCP
|
US |
|
M
|
Marqeta Inc
NASDAQ:MQ
|
US |
|
5
|
5E Advanced Materials Inc
NASDAQ:FEAM
|
US |
|
ALK-Abello A/S
F:4AJ0
|
DK |
|
A
|
ASOS PLC
OTC:ASOMF
|
UK |
|
Pfizer Ltd
NSE:PFIZER
|
IN |
Shareholder Yield
Current shareholder yield for GLSI is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GLSI Price
Greenwich Lifesciences Inc
| Average Annual Return | -24.48% |
| Standard Deviation of Annual Returns | 23.19% |
| Max Drawdown | -85% |
| Market Capitalization | 190.4m USD |
| Shares Outstanding | 14 680 000 |
| Percentage of Shares Shorted | 19.05% |
